BioSpace News Archive

Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that, further to the announcement of the 11 March 2019, the Company has pledged its holding of Polarean Imaging plc (“Polarean”) as additional security against the loan facility (the “Facility”) with the Company’s debt provider (“the Lender”).

PharmaMar (PHM:MSE) has been notified by the lead author, Dr. Luis Paz-Ares, MD, PhD, Professor of Medicine at the Hospital Universitario 12 de Octubre in Madrid, Spain, that the abstract titled “Efficacy and safety profile of Lurbinectedin in second-line SCLC patients: results from a phase II single-agent trial” has been accepted by ASCO (American Society of Clinical Oncology) and has been selected for an oral presentation at the 19th Annual Meeting in Chicago, Illinois.

Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announces the appointment of Ian Smith, M.D., as Chief Medical Officer

Waters Corporation (NYSE:WAT) announced today Terry Kelly is stepping down as President of TA Instruments effective immediately.